You probably already know that GBM is a vicious, deadly disease. The question we all have is, what are we going to do about it? As we approach the fourth annual GBM Awareness Day on July 20, 2022, we’re asking you to get involved.
Go behind the scenes of the nation’s largest brain tumor conference and hear why the co-chairs say you don’t want to miss this year’s event, Sept. 9-10!
Dr. Duane Mitchell, MD, PhD, Univ. of Florida, shares four highlights in recent GBM research and what he’s hopeful for in the future.
What started as a small golf outing to remember a beloved friend lost to brain cancer has blossomed into 25 years of a shining legacy and more than $660,000 for crucial brain tumor research.
**Sponsored Content**
Referred to as the “center point of progress in modern oncology,” biomarker testing opens up a world of targeted therapies that can guide an oncology treatment plan and turn more patients into survivors.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
